Yes someone needs to quote some of those 500k/month sales promises, I noticed these much hyped sales levels seemed to fall by the wayside (presumably have not been reached?).
These are earlier posts quited from other members..
29/10/10
Halcion Pathology business no cash, purchased through share placement (Pending SH Approval). Current Revenue 7.5M, with a forecast to double Revenue with a gross Margin of Approx. 25%. June 2011 Forecast Revenue $12M and June 2012 Forecast Revenue $20M
From Announcement on 28 October 2010-10-29 - As reported earlier this week with early initial monthly revenues approaching in the order of $1.5 million per month (AND GROWING - Note Includes Halcion Revenue), these sales, which will become evident and reportable in the Companys first Quarter of the New Year. Verification of sales.
27/10/10 I must say I am surprised by the impressive cash flows already being generated but surprises like this make up for the suppressed share price.
I'm too lazy, but has anyone reviewed the first quarter revenues and compared to announcements, to see how closely they aligned (the 'approaching' statement should be able to be confirmed as truth or fiction).
Something I really don't get, is the Halcion deal never went ahead, but it sounds like revenues reported on late last year included revenues from Halcion ("includes Halcion revenue"), before the acquisition had taken place. How exactly does that work??? You can't include a yet-to-be acquired companies revenues in your own cashflow statements.. or can you..
STI Price at posting:
0.4¢ Sentiment: None Disclosure: Not Held
